First Tracks Biotherapeutics Stock

First Tracks Biotherapeutics EBITDA per Share

The EBITDA per Share of First Tracks Biotherapeutics (TRAX) as of Aug 6, 2026 is -5.15 USD.

EBITDA per Share

-5.15USD

Last updated:

EBITDA per Share of First Tracks Biotherapeutics is 2026 -5.15 USD. EBITDA per Share of First Tracks Biotherapeutics was 2025 0.00 USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

First Tracks Biotherapeutics Stock analysis

What does First Tracks Biotherapeutics do? First Tracks Biotherapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about First Tracks Biotherapeutics stock

EBITDA per Share of First Tracks Biotherapeutics is -5.15 USD in 2026.

On Eulerpool you can find the complete historical development of EBITDA per Share First Tracks Biotherapeutics since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — First Tracks Biotherapeutics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — First Tracks Biotherapeutics